| 摘要 |
The invention relates to novel crystalline modifications of N-E-(2,4,6-triisopropylphenylsulfonyl)-3-hydroxyamidino-(L)-phenylalanine-4-ethoxycarbonylpiperazide and/or salts thereof, which can be used as pharmaceutical agents. The invention also relates to said novel crystalline modifications containing pharmaceutical compositions and to pharmaceutical uses.
|
